Yu‐Cheng Zhao

Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)

Jian‐Jun Li, Zongliang Lu, Wen‐Rong Kou et al. · The Journal of Clinical Pharmacology · 2009 · 58 citations

Medicine, Cardiology, Pharmacotherapy +17

Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

Jian‐Jun Li, Zongliang Lu, Wen‐Rong Kou et al. · Annals of Medicine · 2010 · 48 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effect of Xuezhikang on Cardiovascular Events and Mortality in Elderly Patients with a History of Myocardial Infarction: A Subgroup Analysis of Elderly Subjects from the China Coronary Secondary Prevention Study

Ping Ye, Zongliang Lu, Bao‐min Du et al. · Journal of the American Geriatrics Society · 2007 · 48 citations

Medicine, Cardiology, Pharmacotherapy +17

Xuezhikang, An Extract of Cholestin, Reduces Cardiovascular Events in Type 2 Diabetes Patients With Coronary Heart Disease: Subgroup Analysis of Patients With Type 2 Diabetes From China Coronary Secondary Prevention Study (CCSPS)

Shui‐Ping Zhao, Zongliang Lu, Bao‐min Du et al. · Journal of Cardiovascular Pharmacology · 2007 · 38 citations

Medicine, Cardiology, Pharmacology +15

Long-Term Effects of Xuezhikang on Blood Pressure in Hypertensive Patients with Previous Myocardial Infarction: Data from the Chinese Coronary Secondary Prevention Study (CCSPS)

Jian‐Jun Li, Zongliang Lu, Wen‐Rong Kou et al. · Clinical and Experimental Hypertension · 2010 · 19 citations

Medicine, Cardiology, Pharmacotherapy +15